IceCure Medical Statistics
Total Valuation
ICCM has a market cap or net worth of $54.88 million. The enterprise value is $44.41 million.
| Market Cap | 54.88M |
| Enterprise Value | 44.41M |
Important Dates
The last earnings date was Wednesday, April 3, 2024, before market open.
| Earnings Date | Apr 3, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICCM has 45.73 million shares outstanding. The number of shares has increased by 23.29% in one year.
| Shares Outstanding | 45.73M |
| Shares Change (YoY) | +23.29% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 59.30% |
| Owned by Institutions (%) | 0.66% |
| Float | 18.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.99 |
| Forward PS | 11.74 |
| PB Ratio | 4.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.66 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 16.86 |
Financial Efficiency
Return on equity (ROE) is -87.00% and return on invested capital (ROIC) is -122.05%.
| Return on Equity (ROE) | -87.00% |
| Return on Assets (ROA) | -68.60% |
| Return on Capital (ROIC) | -122.05% |
| Revenue Per Employee | $45,479 |
| Profits Per Employee | -$206,366 |
| Employee Count | 71 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 0.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.03% in the last 52 weeks. The beta is 2.97, so ICCM's price volatility has been higher than the market average.
| Beta (1Y) | 2.97 |
| 52-Week Price Change | -7.03% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 42.65 |
| Average Volume (30 Days) | 712,945 |
Short Selling Information
The latest short interest is 299,759, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 299,759 |
| Short Previous Month | 353,558 |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, ICCM had revenue of $3.23 million and -$14.65 million in losses. Loss per share was -$0.32.
| Revenue | 3.23M |
| Gross Profit | 1.30M |
| Operating Income | -15.58M |
| Pretax Income | -14.65M |
| Net Income | -14.65M |
| EBITDA | -15.25M |
| EBIT | -15.58M |
| Loss Per Share | -$0.32 |
Balance Sheet
The company has $11.06 million in cash and $599,000 in debt, giving a net cash position of $10.46 million or $0.23 per share.
| Cash & Cash Equivalents | 11.06M |
| Total Debt | 599,000 |
| Net Cash | 10.46M |
| Net Cash Per Share | $0.23 |
| Equity / Book Value | 12.16M |
| Book Value Per Share | 0.27 |
| Working Capital | 10.31M |
Cash Flow
In the last 12 months, operating cash flow was -$12.52 million and capital expenditures -$480,000, giving a free cash flow of -$13.00 million.
| Operating Cash Flow | -12.52M |
| Capital Expenditures | -480,000 |
| Free Cash Flow | -13.00M |
| FCF Per Share | -$0.29 |
Margins
Gross margin is 40.26%, with operating and profit margins of -482.38% and -453.76%.
| Gross Margin | 40.26% |
| Operating Margin | -482.38% |
| Pretax Margin | -453.76% |
| Profit Margin | -453.76% |
| EBITDA Margin | -472.38% |
| EBIT Margin | -482.38% |
| FCF Margin | -402.63% |
Dividends & Yields
ICCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.29% |
| Shareholder Yield | -23.29% |
| Earnings Yield | -26.70% |
| FCF Yield | -23.69% |
Analyst Forecast
The average price target for ICCM is $2.95, which is 147.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.95 |
| Price Target Difference | 147.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 10, 2021. It was a reverse split with a ratio of 1:8.
| Last Split Date | Aug 10, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
ICCM has an Altman Z-Score of -2.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.11 |
| Piotroski F-Score | 3 |